Advertisement

Physician’s Briefing Weekly Coronavirus Roundup

0
Here is what the editors at Physician's Briefing chose as the most important COVID-19 developments for you and your practice for the week of...

FDA Moves to Resume Use of J&J COVID Vaccine

0

Johnson & Johnson has agreed with the U.S. Food and Drug Administration to add a warning label to the vaccine

Decrease Seen in Abusive Head Trauma for Young Children During Pandemic

0

Mean monthly admissions for AHT in children younger than 5 were lower in 2020 than in 2019, 2018, and 2017

Guidance Updated for Assessing Allergy Risk of COVID-19 Vaccines

0

Janssen adenovirus type 26 vectored vaccine may be considered for individuals who self-report PEG allergy

Traumatic Brain Injury Ups Risk for Future Stroke

0

Findings show highest risk in the first four months post-TBI, but risk remains regardless of severity or type of injury

Mechanism ID’d for Thrombosis After ChAdOx1 nCoV-19 Vaccine

0

Testing for antibodies to platelet factor 4 positive in 22 of 23 patients; treatment with platelet transfusion should be avoided

Sex Disparities in COVID-19 Deaths Not Seen Across Race

0

However, Black women have COVID-19 mortality rates nearly four times higher than White men, three times higher than Asian men

ACP Offers Guidance on Antibiotic Duration for Common Infections

0

Best practices recommend limiting antibiotics to five days for COPD exacerbations, acute uncomplicated bronchitis

Introduction of Sepsis Performance Measure Had Little Impact

0

Variable impact found on changes in process measures, with no improvement in clinical outcomes

Proportion of Black Physicians Has Changed Little Since 1900

0

Racial income differences were statistically significant each survey year, with difference of $50,000 in 2018